Your browser doesn't support javascript.
loading
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes.
Sunnarborg, Katriina; Tiihonen, Miia; Huovinen, Marjo; Koponen, Marjaana; Hartikainen, Sirpa; Tolppanen, Anna-Maija.
  • Sunnarborg K; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Tiihonen M; Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland.
  • Huovinen M; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Koponen M; Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland.
  • Hartikainen S; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
  • Tolppanen AM; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
Pharmacoepidemiol Drug Saf ; 31(8): 875-882, 2022 08.
Article en En | MEDLINE | ID: mdl-35505634

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article